Feb 14 (Reuters) - Aurinia Pharmaceuticals Inc AUP.TO
* Aurinia Pharmaceuticals Inc announces results from Japanese Phase I ethnic bridging study for Voclosporin
* Aurinia Pharmaceuticals Inc - data support continued development of Voclosporin in Japanese patient population
* Aurinia Pharmaceuticals Inc - there were no unusual or unexpected safety signals in study.
* Aurinia - PK parameters in Japanese patients were generally consistent with previously evaluated PK parameters in non-Japanese volunteers
* Aurinia Pharmaceuticals Inc says to share findings of study with Japanese pharmaceuticals, medical devices agency in Q2, Source text for Eikon: ID:nBw810G9Wa Further company coverage: AUP.TO